What Is an Optometry Practice Worth in 2026? A Seller's Valuation Guide

Optometry practices are commanding 2.0x to 3.5x SDE at the small end and 6.0x to 8.0x EBITDA for larger groups in 2026, with a national median around 4.7x EBITDA. That is a very wide spread, and where your practice lands inside it has far more to do with how the practice is built than with the eye care itself. After a more cautious 2025, buyers are still active — they are just more disciplined, which rewards the prepared seller and punishes the one who walks in unready.

Who this is for: optometry practice owners with at least $400K in owner earnings who are thinking about an exit in the next one to three years and want to understand what their practice is realistically worth before they ever talk to a buyer.

How are optometry practices valued in 2026?

Smaller practices are valued on Seller's Discretionary Earnings — your profit plus your salary and personal add-backs — and typically trade at 2.0x-3.5x SDE, which works out to roughly 0.43x-0.75x annual revenue. Once a practice has associate optometrists generating revenue independent of the owner and clears about $1M in EBITDA, buyers shift to an EBITDA multiple, and that is where the 6.0x-8.0x platform numbers live. The most important thing to understand is that the multiple is only half the equation; how a buyer defines and adjusts EBITDA determines your actual payout, and two offers at the same headline multiple can differ enormously once you account for add-backs, rollover equity, and earnouts.

What are current optometry multiples?

The national median sits around 4.7x EBITDA, but the average obscures a wide range. A strong multi-doctor group in a desirable market with a profitable optical dispensary can reach 6.0x-8.0x EBITDA, while a solo practice in a rural area may settle closer to 1.0x-1.5x SDE. The differentiators are scale, associate-driven revenue, payer mix, and the quality of the financials. Private equity pulled back in 2025, so the buyers still writing checks are choosier — they reward operational efficiency and clean documentation, and they discount heavily for anything that looks like single-doctor dependence. For more on which buyers are most active and what they target, see my breakdown of PE firms buying optometry practices in 2026.

Who is buying optometry practices right now?

The active buyer pool is dominated by national platforms and regional MSOs: MyEyeDr., EyeCare Partners, and National Vision, alongside regional management services organizations and the occasional individual optometrist for smaller offices. These platform buyers are systematic — they know exactly what they want, they move efficiently when a practice fits, and they pass quickly when it does not. With more than 13,000 eye care practices in the U.S., consolidators have plenty of options, which is precisely why a well-prepared practice with clean books and associate depth commands attention and a premium while an unprepared one struggles to get a competitive look.

What makes an optometry practice worth more?

The premium practices share a profile. They have associate optometrists driving a meaningful share of revenue, so the business is not betting on the owner's personal patient relationships. They run a profitable optical dispensary and capture strong managed-care and private-pay mix. Their books are clean, with clear separation between personal and practice expenses and well-documented add-backs. They have an office manager and systems that survive the owner's exit. And they show steady patient volume and recall rates that give a buyer confidence the revenue continues after closing. Each of these is a lever you can pull before you sell.

What hurts optometry valuations?

The biggest value-killer is owner dependence — if every exam, every key patient relationship, and every management decision runs through you, a buyer sees risk and discounts the multiple or loads the price with earnouts. Messy financials are next: commingled personal spending, undocumented cash, and no clean EBITDA bridge force a buyer to assume the worst. Heavy concentration in one payer or one referral source, an aging equipment base, a declining patient panel, and a lease that does not transfer cleanly all chip away at the number. Most of these are fixable with 12-18 months of disciplined preparation.

How long does it take to sell?

A well-run optometry practice sale takes 6 to 12 months from go-to-market to close. Plan on two to three months to normalize financials and prepare materials, six to ten weeks of buyer outreach and meetings, and then 60 to 90 days for the buyer's quality-of-earnings review, confirmatory diligence, and legal documentation. Rushing the process usually costs money, because leverage belongs to the prepared seller who is not in a hurry.

I worked with an optometrist who was sure her practice was "a 3x business" because that is what a colleague had been offered. The difference was that she had spent two years building an associate OD into a real revenue producer and cleaning up her optical margins. When we took her to market, the practice no longer depended on her personally, and a regional MSO closed it above 6x EBITDA. The exams never changed — the structure of the business did.